Bandingkan Harga & Kinerja Multikarya Asia Pasifik Raya Tbk. (MKAP) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Multikarya Asia Pasifik Raya Tbk. dan Organon Pharma Indonesia Tbk.: Multikarya Asia Pasifik Raya Tbk. diperdagangkan di Rp1.115 (kapitalisasi pasar 3,62 T, volume 24 jam 38 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Multikarya Asia Pasifik Raya Tbk. jauh lebih besar — sekitar 34,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| MKAP | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 3,62 T | 104,4 M |
Volume | 38 rb | — |
Lot | 380 | — |
Perputaran | 42,24 jt | — |
Harga Rata-rata | 1.111,46 | — |
Nilai Transaksi | 42,24 jt | — |
Harga Ekuilibrium Indikatif | 1.115 | — |
Volume Ekuilibrium Indikatif | 300 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Multikarya Asia Pasifik Raya Tbk.
PT Multikarya Asia Pasifik Raya Tbk (the Company) was established on May 16, 2002 in Jakarta, Indonesia under the name of PT Mudking Asia Pasifik Raya, herein after, based on Notarial Deed No. 43 of Yunardi, S.H. The Company started its commercial operations in 2002.
Selengkapnya di halaman MKAP →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
